Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 3:35 PM UTC

Vireo Growth (VREOF) Total Current Liabilities (2020 - 2026)

Vireo Growth (VREOF) posted Total Current Liabilities of $215.8 million for Q1 2026, up 12.57% sequentially from $191.7 million in Q4 2025, and up 56.77% YoY from $137.7 million in Q1 2025.

Vireo Growth (VREOF) Total Current Liabilities (2020 - 2026) Analysis & Trends

Vireo Growth has reported Total Current Liabilities for 7 years, with the latest figure at $215.8 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 56.77% year-over-year to $215.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215.8 million (up 56.77% YoY) and the FY2025 annual result came in at $191.7 million, up 41.51% from the prior year.
  • Total Current Liabilities rose to $215.8 million in Q1 2026 per VREOF's latest filing, from $191.7 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $243.5 million in Q2 2025 and troughed at $18.5 million in Q2 2022.
  • A 5-year average of $138.3 million and a median of $157.0 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities jumped 747.46% in 2023, then decreased 25.28% in 2025.
  • Over 5 years, Total Current Liabilities stood at $29.7 million in 2022, then jumped by 504.09% to $179.5 million in 2023, then declined by 24.52% to $135.5 million in 2024, then soared by 41.51% to $191.7 million in 2025, then increased by 12.57% to $215.8 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $215.8 million, $191.7 million, and $234.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -8.38 Bn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 15.65 Bn
3 Zoetis 31.79 Bn 30.11 Bn 1.05 Bn 2.06 Bn
4 Takeda Pharmaceutical 28.69 Bn 22.89 Bn 5.10 Bn 17.34 Bn
5 United Therapeutics 22.25 Bn 19.58 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 6.35 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn 874.50 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 1.85 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 1.79 Bn
10 Vireo Growth 487.39 Mn 345.09 Mn 95.30 Mn 390.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 215.80 Mn
Dec 31, 2025 191.70 Mn
Sep 30, 2025 234.91 Mn
Jun 30, 2025 243.52 Mn
Mar 31, 2025 137.66 Mn
Dec 31, 2024 135.47 Mn
Sep 30, 2024 128.77 Mn
Jun 30, 2024 186.77 Mn
Mar 31, 2024 184.24 Mn
Dec 31, 2023 179.47 Mn
Sep 30, 2023 165.42 Mn
Jun 30, 2023 157.00 Mn
Mar 31, 2023 95.17 Mn
Dec 31, 2022 29.71 Mn
Sep 30, 2022 26.35 Mn
Jun 30, 2022 18.53 Mn
Mar 31, 2022 20.52 Mn
Dec 31, 2021 16.41 Mn
Sep 30, 2021 15.23 Mn
Jun 30, 2021 16.11 Mn